Commodore Capital LP Seres Therapeutics, Inc. Transaction History

Commodore Capital LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$5.46 - $22.6 $794,173 - $3.29 Million	-145,453 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$18.46 - $24.36 $76,609 - $101,094	4,150 Added 2.94%	145,453 $3.47 Million
Q1 2021 May 17, 2021	BUY	$17.66 - $28.92 $2.5 Million - $4.09 Million	141,303 New	141,303 $2.91 Million

100

62.7M

36.9K

476K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Commodore Capital LP, based on Form 13F filings with the SEC.

Stay updated on Commodore Capital LP with notifications on news.